IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $17,508,918 | +13.3% | 2,490,600 | -2.3% | 0.18% | +3.4% |
Q1 2023 | $15,446,885 | -6.4% | 2,548,991 | -1.5% | 0.18% | -25.2% |
Q4 2022 | $16,509,003 | -34.6% | 2,587,618 | -4.1% | 0.24% | -26.1% |
Q3 2022 | $25,240,000 | -15.0% | 2,699,413 | -3.6% | 0.32% | -12.3% |
Q2 2022 | $29,704,000 | -24.3% | 2,799,642 | +17.7% | 0.37% | +27.4% |
Q1 2022 | $39,243,000 | -52.5% | 2,378,336 | -52.1% | 0.29% | -33.6% |
Q4 2021 | $82,619,000 | -43.0% | 4,965,096 | -22.2% | 0.43% | -30.3% |
Q3 2021 | $144,972,000 | -27.0% | 6,380,803 | -17.4% | 0.62% | -19.8% |
Q2 2021 | $198,527,000 | +17.3% | 7,724,788 | +44.5% | 0.78% | -6.3% |
Q1 2021 | $169,250,000 | -17.5% | 5,345,861 | +20.8% | 0.83% | -28.9% |
Q4 2020 | $205,269,000 | +76.7% | 4,423,910 | +25.7% | 1.17% | +13.3% |
Q3 2020 | $116,152,000 | +54.1% | 3,519,745 | +27.8% | 1.03% | +4.3% |
Q2 2020 | $75,365,000 | +12.3% | 2,754,568 | +22.9% | 0.99% | +56.9% |
Q1 2020 | $67,086,000 | +82.7% | 2,241,044 | +68.9% | 0.63% | +8.8% |
Q4 2019 | $36,718,000 | +48.7% | 1,326,509 | -2.2% | 0.58% | +31.7% |
Q3 2019 | $24,685,000 | -20.4% | 1,356,302 | +7.3% | 0.44% | -27.8% |
Q2 2019 | $30,996,000 | +603.8% | 1,264,096 | +173.0% | 0.61% | +424.1% |
Q1 2019 | $4,404,000 | – | 463,070 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |